Personalized medicine could soon become common practice in Estonia. A new initiative, backed by a total of €30m ($26m) in funding, is being used to establish a personalized medicine center, building on the existing Estonian Biobank, which was set up in 2000 and has sequenced more than 200,000 genomes – representing around 20% of the country’s adult population.
Estonian Biobank’s Personalized Medicine Project To Unlock New Insights For Drug R&D
A new center for personalized medicine in Estonia will see PacBio’s long-read whole genome sequencing technology used to unlock new information about how genetics impact patients’ drug responses, experts from the project tell the Pink Sheet.
More from Europe
More from Geography
• By
While the pharma industry appears to be exempt from US tariffs imposed by President Trump, a member of the UK House of Lords says the details are unknown and warned that uncertainty “leads to less investment” in business as a whole.
• By
The EU Clinical Trials Information System has achieved primary registry designation in the International Clinical Trials Registry Platform in a move that is expected to reduce regulatory burden for companies and help them lower compliance costs by aligning with publication requirements in medical journals.
• By
The UK government has listened to industry concerns about high clawback rates under the voluntary scheme and will review it in June in a bid to resolve the issue and “move on to bigger and more important things,” health secretary Wes Streeting says.